KR101387695B1 - The anti-diabetic composition mainly containing extracts of kudzu root, Solomon's seal and E. senticosus - Google Patents

The anti-diabetic composition mainly containing extracts of kudzu root, Solomon's seal and E. senticosus Download PDF

Info

Publication number
KR101387695B1
KR101387695B1 KR1020120049758A KR20120049758A KR101387695B1 KR 101387695 B1 KR101387695 B1 KR 101387695B1 KR 1020120049758 A KR1020120049758 A KR 1020120049758A KR 20120049758 A KR20120049758 A KR 20120049758A KR 101387695 B1 KR101387695 B1 KR 101387695B1
Authority
KR
South Korea
Prior art keywords
extract
weight
solid content
audi
root
Prior art date
Application number
KR1020120049758A
Other languages
Korean (ko)
Other versions
KR20130126022A (en
Inventor
김호경
Original Assignee
주식회사 파낙스코리아
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 파낙스코리아 filed Critical 주식회사 파낙스코리아
Priority to KR1020120049758A priority Critical patent/KR101387695B1/en
Publication of KR20130126022A publication Critical patent/KR20130126022A/en
Application granted granted Critical
Publication of KR101387695B1 publication Critical patent/KR101387695B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/254Acanthopanax or Eleutherococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/488Pueraria (kudzu)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/60Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605Morus (mulberry)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962Allium, e.g. garden onion, leek, garlic or chives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8969Polygonatum (Solomon's seal)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/328Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Botany (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

본 발명은 자연 재료를 최적으로 선정 배합하여 우수한 항당뇨 효과를 얻도록 한 항당뇨 조성물에 관한 발명으로, 더욱 상세하게는 갈근, 둥굴레 줄기, 오디의 엑기스를 주성분으로 해서 배합한 항당뇨 조성물에 관한 것이다.
본 발명은 갈근 엑기스, 둥굴레 줄기 엑기스, 오디 엑기스를 주성분으로 한다.
이때 갈근 엑기스는 18~22중량%, 둥굴레 줄기 엑기스는 13~17중량%, 오디 엑기스는 13~17중량% 함유하는 것을 특징으로 한다.
The present invention relates to an antidiabetic composition in which natural ingredients are optimally selected and blended to obtain an excellent antidiabetic effect. More particularly, the present invention relates to an antidiabetic composition comprising a root extract, a round stem, and an extract of Audi as a main component. will be.
The present invention has a root extract, a round stem extract, an Audi extract as a main component.
At this time, the root extract is 18 to 22% by weight, the round stalk extract is 13 to 17% by weight, Audi extract is characterized in that it contains 13 to 17% by weight.

Description

갈근, 둥굴레 줄기 및 오디의 엑기스를 주성분으로 하는 항당뇨 조성물{The anti-diabetic composition mainly containing extracts of kudzu root, Solomon's seal and E. senticosus}The anti-diabetic composition mainly containing extracts of kudzu root, Solomon's seal and E. senticosus}

본 발명은 자연 재료를 최적으로 선정 배합하여 우수한 항당뇨 효과를 얻도록 한 항당뇨 조성물에 관한 발명으로, 더욱 상세하게는 갈근, 둥굴레 줄기, 오디의 엑기스를 주성분으로 해서 배합한 항당뇨 조성물에 관한 것이다.The present invention relates to an antidiabetic composition in which natural ingredients are optimally selected and blended to obtain an excellent antidiabetic effect. More particularly, the present invention relates to an antidiabetic composition comprising a root extract, a round stem, and an extract of Audi as a main component. will be.

본 발명에 따르면 자연 재료를 이용함으로써 약물 사용에 따른 부작용을 없애면서도 적절한 재료의 배합을 통해 우수한 항당뇨 효과를 거둘 수 있다.
According to the present invention it is possible to achieve an excellent anti-diabetic effect through the combination of the appropriate ingredients while eliminating the side effects of the use of natural materials.

당뇨병은 인슐린이 비정상적으로 분비되거나 분비되더라도 제대로 작용하지 못하여 포도당 대사가 원활하게 이루어지지 않는 질병이다. 인슐린은 포도당의 이용을 촉진하여 대사조절을 하기 때문에 이 작용이 부족해질 경우 포도당이 제대로 이용되지 못하고 신체세포는 에너지 부족상태에 빠지게 된다. 혈액 중의 포도당은 이용되지 않고 잔류하여 당뇨병의 특징인 고혈당이 된다.Diabetes is a disease in which glucose metabolism does not work well even if insulin is secreted or secreted abnormally. Insulin promotes the use of glucose to regulate metabolism, so when this action is insufficient, glucose is not properly used and body cells are in a state of energy deprivation. Glucose in the blood remains unused and becomes hyperglycemic, a hallmark of diabetes.

당뇨병은 서구의 식생활과 비슷해지면서 생긴 비만, 고혈압, 심장병, 동맥경화 같은 성인병 중 하나이다. 성인 인구의 10%를 차지할 만큼 심각한 문제로 대두되고 있고, 그 합병증 또한 심각하여 당뇨성 신경장애, 망막증, 동맥경화증 등을 유발하여 뇌졸중이나 심장병을 부른다.Diabetes is one of the adult diseases such as obesity, high blood pressure, heart disease, and arteriosclerosis caused by a similar diet to the Western diet. It is a serious problem that accounts for 10% of the adult population, and its complications are also serious, causing diabetic neuropathy, retinopathy, and atherosclerosis, leading to stroke or heart disease.

당뇨병에는 두 가지 유형이 있다. 제1형 당뇨병은 인슐린 의존형으로 유전적 요인에 의해 β세포가 파괴되는 것으로 알려져 있다. 인슐린을 전혀 생산하지 못하는 게 원인이 되어 발생한다.There are two types of diabetes. Type 1 diabetes mellitus is insulin dependent, and β cells are known to be destroyed by genetic factors. It is caused by not producing any insulin at all.

제2형 당뇨병은 인슐린 비의존형 또는 성인형 당뇨병이라고도 한다. 비만, 스트레스, 식생활 잘못, 또는 인슐린과 길항(拮抗)하는 약물 등에 의해 발병하며 전체 당뇨병 환자의 95% 이상이 제2형 당뇨병에 속한다.
Type 2 diabetes is also referred to as insulin independent or adult diabetes. It is caused by obesity, stress, poor diet, or drugs that antagonize insulin, and more than 95% of all diabetics belong to type 2 diabetes.

당뇨병의 원인은 아직까지 정확히 밝혀지지 않았으며 유전, 비만, 바이러스 감염, 스트레스, 약물남용, 운동부족 등과 관련이 있는 것으로 알려져 있다. 정확한 원인을 밝히지 못했듯이 완치가 어려운 질병으로 여겨지며 치료 또한 쉽지 않다.The cause of diabetes is not known yet, and it is known to be related to heredity, obesity, viral infections, stress, drug abuse, and lack of exercise. As the exact cause is not known, it is considered difficult to cure and difficult to treat.

서양의학 치료법의 경우, 경구혈당강하제나 인슐린 주사 등의 약물요법에 의한 혈당 조절관리에 치중하면서 규칙적인 식사와 운동으로 당뇨를 조절하는데 실제 당사자는 식이조절, 규칙적 운동, 주사제 투입 등의 치료법이 쉽지 않다. 또한 시중에서 판매하는 약물의 대부분은 끊임없이 복용해야 하므로, 약물의 장기 투여로 말미암아 나타나는 부작용을 감수해야 한다.
In Western medicine, diabetes is controlled by regular diet and exercise while focusing on glycemic control by oral hypoglycemic drugs or insulin injections. not. Also, most of the drugs on the market must be taken on an ongoing basis, so bear the side effects of long-term administration of the drug.

본 발명은 상기와 같은 배경에서 안출된 것으로, 자연 재료를 이용하여 약물 사용에 따른 부작용을 없애면서도 그 배합을 적절히 하여 우수한 항당뇨 효과를 보이는 조성물을 제공하는 데 그 목적이 있다.The present invention has been made in the background as described above, the object of the present invention is to provide a composition exhibiting excellent anti-diabetic effect by appropriately blending while eliminating side effects due to drug use using natural materials.

본 발명의 조성물은 액상 형태이므로 환자가 섭취하기가 매우 용이하며 이를 섭취할 경우 혈중 당 함량이 지속적으로 떨어지게 된다.
Since the composition of the present invention is in liquid form, it is very easy for the patient to ingest, and when ingested, the blood sugar content continuously decreases.

상기와 같은 본 발명은 갈근 엑기스, 둥굴레 줄기 엑기스, 오디 엑기스를 주성분으로 하는 항당뇨 조성물인 것을 특징으로 한다.The present invention as described above is characterized in that the anti-diabetic composition, the main component of the root extract, the round stem extract, the Audi extract.

더 구체적으로 본 발명의 항당뇨 조성물은 갈근 엑기스 18~22중량%, 둥굴레 줄기 엑기스 13~17중량%, 오디 엑기스는 13~17중량%를 함유하는 것을 특징으로 한다.More specifically, the anti-diabetic composition of the present invention is characterized in that it contains 18-22% by weight of the root extract, 13-17% by weight of the oleander stem extract, and 13-17% by weight of the Audi extract.

더 구체적으로 갈근 엑기스 20중량%, 둥굴레 줄기 엑기스 15중량%, 오디 엑기스 15중량%, 양파 엑기스 15중량%, 가시오가피 엑기스 15중량%, 솔잎 엑기스 13.5중량%, 비타민 C 2중량%, 비타민 E 2중량%, 홍삼 엑기스 2중량%, 치커리 식이섬유 0.5중량%로 이루어지는 것을 특징으로 한다.More specifically, 20% by weight of the root extract, 15% by weight of the round stalk extract, 15% by weight of the Audi extract, 15% by weight of the onion extract, 15% by weight of the skin extract, pine needle extract 13.5%, vitamin C 2% by weight, vitamin E 2% %, Red ginseng extract 2% by weight, chicory dietary fiber is characterized by consisting of 0.5% by weight.

이때 갈근 엑기스의 고형분은 15~20중량%, 둥굴레 줄기 엑기스의 고형분은 20~25중량%, 오디 엑기스의 고형분은 20~25중량%, 양파 엑기스의 고형분은 20~25중량%, 가시오가피 엑기스의 고형분은 20~25중량%, 솔잎 엑기스의 고형분은 20~25중량%, 홍삼 엑기스의 고형분은 60~65중량%인 것을 특징으로 한다.At this time, the solid content of the root extract is 15-20% by weight, the solid content of the round stalk extract is 20-25% by weight, the solid content of the Audi extract is 20-25% by weight, the solid content of the onion extract is 20-25% by weight, the solid content of the skin extract Silver is 20-25% by weight, solid content of pine needle extract is 20-25% by weight, solid content of red ginseng extract is characterized in that 60-65% by weight.

또한 이때 갈근 엑기스, 둥굴레 줄기 엑기스, 오디 엑기스, 양파 엑기스 및 가시오가피 엑기스는, (1) 각 원료를 선별 정선하여 추출기에 넣고 물을 가하여 80~90에서 추출한 후, (2) 그 추출물을 감압농축기에서 농축한 다음, (3) 물로 고형분의 양을 정해진 수치범위로 조절하여 준비한 것임을 특징으로 한다.
Also, at this time, the root extract, round stalk extract, audi extract, onion extract and thorny oocyte extract, (1) select each raw material, select it, put it in an extractor, add water and extract it at 80 ~ 90, and then (2) extract the extract in a reduced pressure concentrator. After concentration, (3) characterized in that prepared by adjusting the amount of solids to a predetermined numerical range with water.

본 발명에서 사용되는 주원료들에 대해 설명한다.The main raw materials used in the present invention will be described.

갈근은 석류가 갖는 식물성 에스트로겐이 625배나 많은 것처럼 장점이 많은 천연원료이다. 식이섬유질이 풍부하고 사포닌 성분 또한 많이 함유되어 있어서 당뇨, 고혈압에 좋다. 갈근은 땅속에서 물 및 영양분을 빨아들여 굵은 몸속에 저장한다. 섭취하게 되면 사람의 몸속에서 수분 및 영양분을 조절하여 피로회복(간 기능 회복), 부종, 황달 등에 큰 효과를 볼 수 있다.Brown root is a natural ingredient with many advantages, such as 625 times more phytoestrogens in pomegranates. It is rich in dietary fiber and contains a lot of saponin, which is good for diabetes and high blood pressure. The reed sucks water and nutrients from the ground and stores them in a thick body. When ingested, the body's body can control moisture and nutrients, which can have a great effect on fatigue (recovering liver function), edema, jaundice, etc.

둥굴레 줄기는 약리적으로 혈압과 심장, 혈당에 주로 작용한다. 둥굴레 줄기는 허약 체질, 폐결핵, 마른기침, 갈증에 좋으며, 심장을 튼튼하게 하므로 심장쇠약, 협심증 등 심장 질환이 있는 사람에게도 좋다. 또 식은땀과 원인 모르게 얼굴로 열이 오르면서 가슴이 답답하거나 수족에 열감이 있어 갑갑하게 느껴지는 사람, 노화방지에도 더불어 좋은 천연식품이다.It is pharmacologically acting mainly on blood pressure, heart and blood sugar. Duckle stem is good for weak constitution, pulmonary tuberculosis, dry cough, thirst, and strengthens the heart, so it is good for people with heart disease, such as heart failure, angina pectoris. It is also a good natural food for people who feel frustrated due to cold sweating and fever with their face unknowingly causing the chest to feel stuffy or have limbs in their hands and feet.

양파는 혈액 속의 불필요한 지방과 콜레스테롤을 녹여 동맥경화와 고지혈증을 예방하며, 고혈압 예방과 치료에도 탁월하고, 혈당을 저하시키는 작용과 인슐린의 분비를 촉진시켜 당뇨병 예방 및 치료에 좋은 재료이다. 지방의 함량이 적고 채소로서는 단백질이 많은 편이라 고른 영양섭취에 필요하다. 또한 칼슘과 철분의 함량이 많아 강장효과를 돋우는 역할을 한다. 혈액을 정화하기 때문에 피부미용에도 좋고 잔주름을 예방한다.Onion dissolves unnecessary fat and cholesterol in the blood to prevent atherosclerosis and hyperlipidemia. It is also excellent for preventing and treating hypertension, and it is a good material for preventing and treating diabetes by promoting the action of lowering blood sugar and promoting insulin secretion. It is low in fat and contains a lot of protein as a vegetable, so it is necessary for even nutrition. In addition, it has a high content of calcium and iron, which plays a role in enhancing the tonic effect. It cleanses the blood, so it is good for skin care and prevents fine lines.

가시오가피는 생리학적으로 전반적인 기능 증대, 대사촉진작용, 동맥혈압의 정상화, 항염작용, 항암작용, 항당뇨작용, 해독작용, 환경변화에 대한 적응능력 향상 등의 약리 효능을 갖고 있다.Psoriasis has pharmacological effects such as physiological improvement of overall function, metabolic promoting action, normalization of arterial blood pressure, anti-inflammatory action, anticancer action, antidiabetic action, detoxification action and improvement of adaptation ability to environmental changes.

오디는 신체의 모든 기능들을 전체적으로 향상하고 눈과 귀를 맑게 만들어 주는 효능이 있다. 오디는 유리당 성분 조성 및 혈당저하 성분을 함유하고 있다. 혈당을 떨어뜨려 주는 성분으로 알려진 디엔제이(DNJ)를 뽕잎과 같은 정도로 함유하고 있을 뿐만 아니라 오디 속에 존재하는 당분은 과당과 포도당만으로 조성되어 있어 설탕을 배제시켜야 하는 당뇨환자식 등에 매우 유용하다. 또한 고혈압 억제물질 루틴을 높게 함유하고 있으며 불포화지방산 함량이 87%로 매우 높다. 동의보감도 탕액편에서 "까만 오디는 뽕나무의 정령이 모여 있는 것이며, 당뇨병에 좋고 오장에 이로우며, 오래 먹으면 배고픔을 잊게 해준다"고 한다.
Audi has the effect of improving all the functions of the body as a whole and clearing eyes and ears. Audi contains a free sugar component composition and a hypoglycemic component. DJJ, known to lower blood sugar, contains mulberry leaves as much as mulberry leaves, and the sugar present in Audi is composed of fructose and glucose, which is very useful for diabetic patients who need to exclude sugar. In addition, it contains a high level of hypertension inhibitor routines and a very high unsaturated fatty acid content of 87%. Dongbogam is also in the liquid juice "Black Audi is the soul of mulberry trees are gathered, good for diabetes, good for the five chapters, long eating will make you forget hunger."

본 발명은 위와 같은 재료들을 전에 없던 방식과 함량으로 결합한 점에 특징이 있다.
The present invention is characterized by combining the above materials in a manner and in a content that has not been provided before.

본 발명에 따르면 자연 재료를 이용함으로써 약물 사용에 따른 부작용을 없애면서도 적절한 재료의 배합을 통해 우수한 항당뇨 효과를 거둘 수 있다.According to the present invention it is possible to achieve an excellent anti-diabetic effect through the combination of the appropriate ingredients while eliminating the side effects of the use of natural materials.

또한 본 발명의 조성물은 액상 형태이므로 환자가 섭취하기가 매우 용이하다.
In addition, since the composition of the present invention is in liquid form, it is very easy for the patient to consume.

이하 본 발명을 실시예와 함께 상세히 설명한다.
Hereinafter, the present invention will be described in detail with reference to examples.

1. 구성물질 및 함량1. Composition and Content

- 갈근 엑기스(고형분 15%) 20중량%-20% by weight of root extract (solid 15%)

- 둥굴레 줄기 엑기스(고형분 20%) 15중량%-15% by weight of round stalk extract (20% solids)

- 오디추출물(고형분 20%) 15중량%-15% by weight of Audi extract (solid content 20%)

- 양파 엑기스(고형분 20%) 15중량%-15% by weight of onion extract (20% solids)

- 가시오가피 엑기스(고형분 20%) 15중량%-15% by weight of Shigagapi Extract (20% solids)

- 솔잎 엑기스(고형분 20%) 13.5중량%-Pine needle extract (20% solids) 13.5% by weight

- 비타민 C 2중량%2% by weight of vitamin C

- 비타민 E 2중량%2% by weight of vitamin E

- 홍삼 엑기스(고형분 60%) 2중량%-Red ginseng extract (60% solids) 2% by weight

- 치커리 식이섬유 0.5중량%
-0.5% by weight of chicory dietary fiber

2. 2. 항당뇨Anti-diabetic 조성물의 제조 Preparation of composition

원료 갈근을 선별 정선하여 추출기에 넣고 용매(물)를 가하여 90에서 6~7시간씩 3회 반복 추출하였다. 이 추출액을 250mesh 여과기에서 가압식으로 여과하고 감압 농축기에 옮겨 400~700 mmHg, 50~80에서 농축하였다(이때 고형분은 대략 60% 정도였다). 이 농축액에 물을 넣어 고형분 15%로 조정하였다.The raw roots were screened and selected and placed in an extractor, followed by extracting three times at 90 to 6 to 7 hours by adding a solvent (water). The extract was filtered under pressure in a 250mesh filter, transferred to a vacuum concentrator, and concentrated at 400-700 mmHg, 50-80 (at which the solid content was about 60%). Water was added to this concentrate, and the solid content was adjusted to 15%.

둥굴레 줄기, 양파, 가시오가피, 오디, 솔잎, 홍삼의 엑기스도 같은 과정을 통해 위에 같은 방식으로 준비하였다.Extracts of stalks, onions, prickly pears, mulberry, pine needles, and red ginseng were prepared in the same manner.

그다음 위 각 엑기스와 치커리 식이섬유 및 비타민 C, E를 배합하였다.Next, each extract was combined with chicory fiber and vitamins C and E.

치커리 식이섬유는 일반적으로 상품화하여 분말 형태로 판매하는 것을 사용하여도 무방하며 본 실험에서도 그와 같이 하였다.
Chicory dietary fiber is generally commercialized and sold in powder form.

3. 실험3. Experiment

가. 실험동물 : 실험용 수컷 쥐(200±10g)
end. Experimental animal : Experimental male rat (200 ± 10g)

나. 당뇨 유발용 시약I. Diabetic Reagents

당뇨유발 시약 Streptozotocin(sigma S-0130)을 이용하여 실험동물(rat 수컷 체중 200±10g)의 복강에 주사하고 일주일 후 쥐(rat)의 안구에서 채혈한 다음, 혈당측정기를 이용하여 혈당 측정 후, 혈당이 고혈당으로 높아진 쥐를 선발하여 실험동물로 이용하였다.
After injection into the abdominal cavity of the experimental animal (rat male body weight 200 ± 10g) using the diabetes-induced reagent Streptozotocin (sigma S-0130), blood was collected from rat eye one week later, and then blood glucose measurement was performed using a blood glucose meter. Rats whose blood glucose was elevated to hyperglycemia were selected and used as experimental animals.

다. 처리방법All. Processing method

① 당뇨 유발된 쥐를 선발하여 한 처리구에 20수씩을 배치하였다.① Diabetes-induced rats were selected and placed 20 animals in one treatment group.

② 본 발명에 따른 혼합 조성물을 급여하지 않는 대조군과, 3ml/1일/수, 2.5ml/1일/수, 2.0ml/1일/수 등의 급여군으로 나누어 총 4처리구로 하였다. 투여 방법은 존데(sonde)를 이용하여 매일 경구 투여하는 것으로 하였다.② The control composition was not fed the mixed composition according to the present invention and 3ml / 1 day / water, 2.5ml / 1 day / water, 2.0ml / 1 day / water and divided into salary groups such as 4 treatment groups. The administration method was oral administration daily using sonde.

③ 실험기간은 4주일 간 실시하였으며 실험 개시 전 혈당측정을 비롯하여 일주일 간격으로 총 5회에 걸쳐 경구채혈 하여 혈당을 측정하였다.
③ The experiment period was conducted for 4 weeks. Blood glucose was measured by oral blood collection 5 times a week apart from blood glucose measurement before the start of the experiment.

4. 실험 결과4. Experimental Results

가. 체중 측정 결과end. Weight measurement results

실험기간 동안 일주일 간격으로 체중을 측정한 결과 혼합물 투입군은 처음 혈당치가 높았을 때는 체중이 감소하는 결과를 보였으나 3주일이 경과한 후 거의 정상적으로 증가하는 현상을 보였다. As a result of measuring the body weight at weekly interval during the experiment, the mixture group showed a weight loss when the blood sugar level was high for the first time, but increased almost normally after 3 weeks.

반면 대조군(본 발명에 따른 혼합물을 투여하지 않은 쥐)의 경우는 체중이 4주 동안 회복의 기미가 보이지 않았다.
On the other hand, the control group (the rat not administered the mixture according to the present invention) showed no signs of recovery for 4 weeks.

<표 1. 쥐의 4주간 체중 변화><Table 1.Weight Changes in Rats>

Figure 112012037516661-pat00001

Figure 112012037516661-pat00001

<그래프 1. 쥐의 4주간 체중 변화>Graph 1.Weight Changes in Rats>

Figure 112012037516661-pat00002

Figure 112012037516661-pat00002

나. 혈당 측정 결과I. Blood sugar measurement result

혼합물 투여를 한 경우는 2주일 만에 정상수치의 혈당을 얻을 수 있었다. 그래서 3주간만 투여하고 정상수치가 계속 지속되는가를 알아보기 위하여 1주일 동안은 투여하지 않았다.When the mixture was administered, normal blood glucose levels were obtained within two weeks. Therefore, only three weeks of administration and did not administer for a week to see if the normal value continues.

① 미투여군 : 최초 434.90mg/에서 2주일이 지난 후에는 241.10mg/로 회복의 가능성을 보였으나 4주일 경과 후에는 396.44mg/로 악화되었다.(1) Unadministered group: At 2 weeks after the first 434.90mg /, the patient recovered to 241.10mg /, but deteriorated to 396.44mg / after 4 weeks.

② 2.0ml 투여군 : 최초 293.7mg/에서 2주일이 지난 후에는 132.80mg/로 거의 정상적인 회복을 보였으나 4주일 경과 후에는 189.00mg/ 다시 높아지는 경향 보였다.② 2.0ml group: At 2 weeks after the first 293.7mg / 132.80mg / was almost normal recovery, but after 4 weeks 189.00mg / tended to increase again.

③ 2.5ml 투여군 : 최초 263mg/에서 2주일이 지난 후에는 94.8mg/로 완전히 정상으로 측정되었다.③ 2.5ml administration group: After 2 weeks at the first 263mg / 94.8mg / was completely normal.

④ 3.0ml 투여군 : 최초 333.2mg/에서 2주일이 지난 후에는 100.80mg/로 완전히 정상적인 결과를 보였다.
④ 3.0ml group: The first 333.2mg / 2 weeks after 100.80mg / showed a completely normal result.

<표 2. 4주간의 혈당 측정 결과>Table 2. Blood glucose measurement results for 4 weeks

Figure 112012037516661-pat00003

Figure 112012037516661-pat00003

<그래프 2. 4주간의 혈당 측정 그래프><Graph 2. Blood glucose measurement graph for 4 weeks>

Figure 112012037516661-pat00004

Figure 112012037516661-pat00004

<표 3. 혼합물 미투여 쥐와 투여 쥐와의 혈당 비교표>Table 3. Comparison of Blood Glucose Level between Unmixed and Untreated Mice

Figure 112012037516661-pat00005

Figure 112012037516661-pat00005

5. 실험결과에 대한 평가5. Evaluation of Experimental Results

가. 체중 측정 결과의 end. Of weight measurement results 유의미성Significance

당뇨병의 대표적 증상은 다음, 다뇨, 다식이다. 혈액 속의 포도당 농도가 높아지면 혈액에 있는 당분이 소변을 통해서 배설된다. 이때 체내의 수분도 함께 빠져 나가기 때문에 소변의 양과 횟수가 많아지는 것이다. 또 이로 인해 탈수 현상으로 물을 많이 마시게 된다. 사람에 따라 차이는 있지만 하루에 3~4리터 또는 그 이상을 마시는 게 보통이다. 그리고 공복감이 심해져서 식사량이 는다. 이처럼 다식을 하지만 체중은 오히려 빠져서, 심한 경우에는 2~3개월 사이에 10kg까지 빠지는 경우도 있다. 수분은 배출되고 다식을 해도 체중은 오히려 감소하고 체내에 필요한 영양분을 제대로 섭취하지 못하며, 그래서 또 쉽게 피로를 느끼고 무기력감을 느낀다.Representative symptoms of diabetes are the following: polyuria, polyps. As glucose levels in the blood increase, sugar in the blood is excreted in the urine. At this time, the amount of water and the number of urine increases because the body also escapes moisture. In addition, due to the dehydration phenomenon to drink a lot of water. Depending on the person, it is common to drink three to four liters or more per day. And the feeling of fasting worsens, the amount of meals is high. Like this, but the weight is rather missing, in severe cases may fall up to 10kg in 2-3 months. When water is released and you have a lot of food, you lose weight and do not get the nutrients you need, so you can easily feel tired and lethargic.

위 실험에서는 혼합 조성물을 음용했을 때 3주일이 경과한 후 체중이 거의 정상적으로 증가했음을 볼 수 있다. 체중 회복 및 증가의 유의미성은 2.0ml, 2.5ml, 3.0ml 투여군이 모두 갖는다. 실험 전 체중을 정상회복하거나 실험 전보다 증가하는 보다 큰 개선 군은 2.5ml, 3ml 군이라 할 수 있다.In the above experiments, when the mixed composition was drunk after three weeks, the weight can be seen to increase almost normally. Significance of weight recovery and gain was all the 2.0ml, 2.5ml, 3.0ml administration group. The larger improvement group that normalized the weight before the experiment or increased before the experiment could be referred to as the 2.5ml and 3ml groups.

이러한 효과는 혈당치가 낮아진 것과 더불어 중요한 회복의 징후라 볼 수 있다.
These effects, along with lowered blood sugar levels, are important signs of recovery.

나. 혈당 측정 결과I. Blood sugar measurement result

위에 살핀 것처럼 발명자는 당뇨 유발된 쥐들에 발명 혼합물을 투여하지 않거나 투여량을 조절해서 혼합물의 효능 효과를 비교 체크하였다.As shown above, the inventors compared the efficacy effects of the mixtures by not administering the invention mixture or adjusting the dose to the diabetic rats.

그 결과 혼합물을 투여한 쥐들은 대체로 정상적인 혈당치를 보였으나, 투여하지 않은 쥐들은 4주가 지나도 회복의 기미가 없었다. 따라서 본 발명에 따른 추출물은 당뇨에 우수한 효과를 가짐을 알 수 있다.As a result, the rats treated with the mixture generally showed normal blood glucose levels, but the rats without administration showed no signs of recovery after 4 weeks. Therefore, it can be seen that the extract according to the present invention has an excellent effect on diabetes.

한편 혈당 수치 저하의 유의미성은 2.0ml, 2.5ml, 3.0ml 투여군이 모두 갖는다. 실험 전 혈당수치로 정상회복하거나 실험 전보다 수치 이하로서, 보다 큰 개선을 보인 군은 2.5ml, 3ml 군이라 할 수 있다. 상기 결과로 보면, 체중 200±10g의 동물실험에 1일 2.5ml와 3.0ml의 투여가 최상의 효과를 나타냄을 알 수 있는바, 본 발명의 실시 시 제품의 1일 섭취용량에 대한 계산의 토대로 활용할 수 있다.On the other hand, the significance of lowering blood glucose level was all 2.0ml, 2.5ml, 3.0ml administration group. Before the experiment, the blood sugar level returned to normal or below the level before the experiment, and the group showing a greater improvement may be referred to as a 2.5ml, 3ml group. From the above results, it can be seen that the daily administration of 2.5ml and 3.0ml showed the best effect in the animal experiment of body weight 200 ± 10g, and was utilized as a basis for calculation of the daily intake of the product in the practice of the present invention. Can be.

또한 위 실험결과로부터 일정량 이상을 투여할 경우 유의미한 효과를 거둘 수 있음을 알 수 있다.In addition, it can be seen from the above experimental results that a significant amount can be achieved if a certain amount or more is administered.

Claims (5)

갈근 엑기스, 둥굴레 줄기 엑기스, 오디 엑기스, 양파 엑기스, 가시오가피 엑기스, 솔잎 엑기스, 비타민 C, 비타민 E, 홍삼 엑기스 및 치커리 식이섬유로 이루어지는 것을 특징으로 하는 당뇨 예방 및 개선용 식품 조성물.Root extract, gourd stem extract, audi extract, onion extract, prickly pear extract, pine needle extract, vitamin C, vitamin E, red ginseng extract and chicory dietary composition comprising the dietary fiber. 제1항에 있어서,
갈근 엑기스는 18~22중량%, 둥굴레 줄기 엑기스는 13~17중량%, 오디 엑기스는 13~17중량% 함유하는 것을 특징으로 하는 당뇨 예방 및 개선용 식품 조성물.
The method of claim 1,
The root extract is 18-22% by weight, the round stalk extract is 13-17% by weight, the Audi extract is 13 to 17% by weight of the food composition for preventing and improving diabetes.
제2항에 있어서,
갈근 엑기스 20중량%, 둥굴레 줄기 엑기스 15중량%, 오디 엑기스 15중량%, 양파 엑기스 15중량%, 가시오가피 엑기스 15중량%, 솔잎 엑기스 13.5중량%, 비타민 C 2중량%, 비타민 E 2중량%, 홍삼 엑기스 2중량%, 치커리 식이섬유 0.5중량%로 이루어지는 것을 특징으로 하는 당뇨 예방 및 개선용 식품 조성물.
3. The method of claim 2,
20% by weight of brown root extract, 15% by weight of round stalk extract, 15% by weight of audi extract, 15% by weight of onion extract, 15% by weight of barberry extract, 13.5% by weight of pine needles extract, 2% by weight of vitamin C, 2% by weight of vitamin E, red ginseng Extract 2% by weight, dietary fiber composition for preventing and improving diabetes, characterized in that consisting of 0.5% by weight of chicory dietary fiber.
제3항에 있어서,
갈근 엑기스의 고형분은 15~20중량%, 둥굴레 줄기 엑기스의 고형분은 20~25중량%, 오디 엑기스의 고형분은 20~25중량%, 양파 엑기스의 고형분은 20~25중량%, 가시오가피 엑기스의 고형분은 20~25중량%, 솔잎 엑기스의 고형분은 20~25중량%, 홍삼 엑기스의 고형분은 60~65중량%인 것을 특징으로 하는 당뇨 예방 및 개선용 식품 조성물.
The method of claim 3,
The solid content of the root extract is 15-20% by weight, the solid content of the round stalk extract is 20-25% by weight, the solid content of the Audi extract is 20-25% by weight, the solid content of the onion extract is 20-25% by weight, and the solid content of the thorny skin extract is 20-25% by weight, solid content of pine needle extract is 20-25% by weight, solid content of red ginseng extract is 60-65% by weight, the food composition for preventing and improving diabetes.
제4항에 있어서,
갈근 엑기스, 둥굴레 줄기 엑기스, 오디 엑기스, 양파 엑기스 및 가시오가피 엑기스는, (1) 각 원료를 선별 정선하여 추출기에 넣고 물을 가하여 80~90℃에서 추출한 후, (2) 그 추출물을 감압농축기에서 농축한 다음, (3) 물로 고형분의 양을 정해진 수치범위로 조절하여 준비한 것임을 특징으로 하는 당뇨 예방 및 개선용 식품 조성물.
5. The method of claim 4,
Brown root extract, round stalk extract, audi extract, onion extract, and thorny oocyte extract, (1) select each raw material, select it, place it in an extractor, add water and extract it at 80 ~ 90 ℃, and then (2) concentrate the extract in a reduced pressure concentrator. Then, (3) the food composition for preventing and improving diabetes, characterized in that prepared by adjusting the amount of solids to a predetermined numerical range with water.
KR1020120049758A 2012-05-10 2012-05-10 The anti-diabetic composition mainly containing extracts of kudzu root, Solomon's seal and E. senticosus KR101387695B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020120049758A KR101387695B1 (en) 2012-05-10 2012-05-10 The anti-diabetic composition mainly containing extracts of kudzu root, Solomon's seal and E. senticosus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020120049758A KR101387695B1 (en) 2012-05-10 2012-05-10 The anti-diabetic composition mainly containing extracts of kudzu root, Solomon's seal and E. senticosus

Publications (2)

Publication Number Publication Date
KR20130126022A KR20130126022A (en) 2013-11-20
KR101387695B1 true KR101387695B1 (en) 2014-04-21

Family

ID=49854202

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020120049758A KR101387695B1 (en) 2012-05-10 2012-05-10 The anti-diabetic composition mainly containing extracts of kudzu root, Solomon's seal and E. senticosus

Country Status (1)

Country Link
KR (1) KR101387695B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104904942A (en) * 2015-06-05 2015-09-16 王德富 Blood glucose reducing tea and preparation method thereof

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102183687B1 (en) 2017-10-31 2020-11-27 안국건강 주식회사 Extract of Polygonatum odoratum for preventing non-alcoholic fatty liver
CN107875328A (en) * 2017-11-29 2018-04-06 张天文 A kind of integration of drinking and medicinal herbs electuary of the multiple compensation of remaining β cells
CN108308242A (en) * 2018-05-09 2018-07-24 河南中医药大学 A kind of Pueraria lobota fibre biscuit of hypoglycemic defaecation
KR102203094B1 (en) * 2020-09-04 2021-01-14 (주)자연미약선연구원 Composition for preventing and improving menstrual pain and skin troubles

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100795976B1 (en) * 2006-06-13 2008-01-21 동아대학교 산학협력단 Pharmaceutical Composition for Treating or Preventing Diabetes Mellitus Containing an Extract of Chinese Herb as an Effective Ingredient
KR100956278B1 (en) * 2009-08-03 2010-05-10 대한약품공업 주식회사 Composition comprising an extract of herbal combination thereof for preventing and treating diabetes mellitus

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100795976B1 (en) * 2006-06-13 2008-01-21 동아대학교 산학협력단 Pharmaceutical Composition for Treating or Preventing Diabetes Mellitus Containing an Extract of Chinese Herb as an Effective Ingredient
KR100956278B1 (en) * 2009-08-03 2010-05-10 대한약품공업 주식회사 Composition comprising an extract of herbal combination thereof for preventing and treating diabetes mellitus

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104904942A (en) * 2015-06-05 2015-09-16 王德富 Blood glucose reducing tea and preparation method thereof

Also Published As

Publication number Publication date
KR20130126022A (en) 2013-11-20

Similar Documents

Publication Publication Date Title
CN104322617B (en) Biscuit of a kind of auxiliary hyperglycemic and preparation method thereof
CN104026446A (en) Nutritional meal replacement powder suitable for crowd with hyperglycemia and preparation method thereof
KR101387695B1 (en) The anti-diabetic composition mainly containing extracts of kudzu root, Solomon&#39;s seal and E. senticosus
CN102511712A (en) Xylo-oligosaccharide-containing healthcare food auxiliary for blood sugar reduction
CN106975012A (en) A kind of traditional Chinese medicinal composition with effect of reducing blood sugar and preparation method thereof
CN104082672A (en) Health-preserving porridge with efficacy of reducing blood sugar level and production method of porridge
CN105341893A (en) Composition for assisting in reducing blood glucose and application
KR20110019569A (en) Composition of health food
CN103355444A (en) Health care tea paste for tonifying spleen and qi and preparation method
CN102125129B (en) Health care tea
CN102125128A (en) Nine-ingredient blood sugar reducing tea
CN104825821A (en) Medicine for treating diabetes and preparation method thereof
CN107751470A (en) A kind of adlay fruity health tea cream and preparation method thereof
CN107737280A (en) Chinese medicine composition for treating diabetes and its preparation method and application
CN105055851B (en) A kind of Chinese medicine composition that treating diabetes, its preparation and its application
CN104474103A (en) Natural plant hypoglycemic agent and preparation method thereof
CN105733880A (en) Composite hazelnut wine brewed from hazelnut meal
CN111903803A (en) Huangrong blood sugar reducing tea and preparation method thereof
CN103766453A (en) Yam corn biscuit with health care effect on diabetes
Kamala et al. Anti–Hyperglycemic and Anti–Hyperlipidemic Potentials of Psidium guajava Fruit Extract–a Review
CN103721074B (en) Pharmaceutical composition and preparation method and application thereof
CN102000244B (en) Traditional Chinese medicine preparation for treating diabetes mellitus
CN101757114A (en) Hypoglycemic product and preparation method thereof
KR20090126469A (en) The herb extract composition for the blood glucose reducing action
CN104946491A (en) Abalone-holothurian compound wine with blood sugar reducing function

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20180205

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20190515

Year of fee payment: 6